BRPI0418301A - pharmaceutically acceptable compound or salt, method for preparing compound, pharmaceutical composition and therapeutic agent - Google Patents

pharmaceutically acceptable compound or salt, method for preparing compound, pharmaceutical composition and therapeutic agent

Info

Publication number
BRPI0418301A
BRPI0418301A BRPI0418301-0A BRPI0418301A BRPI0418301A BR PI0418301 A BRPI0418301 A BR PI0418301A BR PI0418301 A BRPI0418301 A BR PI0418301A BR PI0418301 A BRPI0418301 A BR PI0418301A
Authority
BR
Brazil
Prior art keywords
pharmaceutical composition
compound
salt
pharmaceutically acceptable
therapeutic agent
Prior art date
Application number
BRPI0418301-0A
Other languages
Portuguese (pt)
Inventor
Hyung Ook Kim
Nam Kyu Lee
Joo Hyon Kim
Hae In Rhee
Young-Baik Cho
Je Ho Ryu
Nam Ho Kim
Jung Bum Yi
Jae Yoon Jung
Keun Ho Ryu
Original Assignee
Sk Chemicals Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sk Chemicals Co Ltd filed Critical Sk Chemicals Co Ltd
Priority claimed from PCT/KR2004/003545 external-priority patent/WO2005063768A1/en
Publication of BRPI0418301A publication Critical patent/BRPI0418301A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

COMPOSTO OU SAL FARMACEUTICAMENTE ACEITáVEL, MéTODO PARA PREPARAR COMPOSTO, COMPOSIçãO FARMACêUTICA E AGENTE TERAPêUTICO Esta invenção refere-se a novos derivados de piridina tendo um efeito inibidor na produção de citocinas, os quais são envolvidos na resposta inflamatória, assim sugerindo suas desvantagens como agentes terapêuticos para tratamento de doenças relacionadas à inflamaçao, sistema imune, inflamação crónica bem como um agente tendo um efeito analgésico e inflamatório. além disso, esta invenção refere-se a um método de fabricar o mesmo e uma composição farmacêutica contendo o mesmo.PHARMACEUTICALLY ACCEPTABLE COMPOUND OR SALT, METHOD FOR PREPARING COMPOUND, PHARMACEUTICAL COMPOSITION AND THERAPEUTIC AGENT This invention relates to novel pyridine derivatives having an inhibitory effect on cytokines, which are involved in the inflammatory response, thus suggesting their disadvantages as therapeutic agents. for treating diseases related to inflammation, the immune system, chronic inflammation as well as an agent having an analgesic and inflammatory effect. furthermore, this invention relates to a method of manufacturing the same and a pharmaceutical composition containing the same.

BRPI0418301-0A 2003-12-30 2004-12-30 pharmaceutically acceptable compound or salt, method for preparing compound, pharmaceutical composition and therapeutic agent BRPI0418301A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20031000132 2003-12-30
PCT/KR2004/003545 WO2005063768A1 (en) 2003-12-30 2004-12-30 Novel pyridine derivatives, a process for their preparation and a pharmaceutical composition containing the same

Publications (1)

Publication Number Publication Date
BRPI0418301A true BRPI0418301A (en) 2007-05-02

Family

ID=38007660

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0418301-0A BRPI0418301A (en) 2003-12-30 2004-12-30 pharmaceutically acceptable compound or salt, method for preparing compound, pharmaceutical composition and therapeutic agent

Country Status (1)

Country Link
BR (1) BRPI0418301A (en)

Similar Documents

Publication Publication Date Title
CY2016031I1 (en) TOPICAL PHARMACEUTICAL FORM OF IVERMECTIN FOR THE TREATMENT OF DERMATOLOGICAL CONDITIONS
ECSP055669A (en) DERIVATIVES OF PYRIMIDINONE AS THERAPEUTIC AGENTS AGAINST REMODELING, ISCHEMICAL AND INFLAMMATORY PROCESSES, ACUTE AND CHRONIC
ECSP056194A (en) DERIVATIVES OF PIRAZOLO-QUINAZOLINA, PROCEDURE FOR ITS PREPARATION AND ITS USE AS QUINASA INHIBITORS
ATE411022T1 (en) PYRIDYLPYRROLE DERIVATIVES AS EFFECTIVE KINASE INHIBITORS
ECSP088869A (en) DERIVATIVES OF 2-PIRAZINONE FOR THE TREATMENT OF DISEASES OR CONDITIONS WHERE THE INHIBITION OF THE ACTIVITY OF NEUTROPHYLICAL ELASTASA IS BENEFICIAL
CR20110608A (en) DERIVATIVES OF 1H-IMIDAZO- [4,5-C] -QUINOLINONA
CL2004001011A1 (en) AZABICICLIC COMPOUNDS DERIVED FROM N-ARILSULFONILPIPERIDINAS; INHIBITORS OF THE DEPOSITION OF PROTEIN BETA AMYLOID; PHARMACEUTICAL COMPOSITION; AND ITS USE FOR THE TREATMENT OF ALZHEIMER AND NEURODEGENERATIVE DISEASES.
DE602004019206D1 (en) ANTI-INFLAMMATORY MEDICINE PREPARATIONS FOR INFLAMMATORY INFLAMMATION AND THE THERAPY OR PROPHYLAXIS OF GASTRIC TOXICITY
ECSP21051825A (en) COMPOUNDS AND THEIR USE FOR THE TREATMENT OF α1-ANTITRYPSIN DEFICIENCY
ATE448232T1 (en) SUBSTITUTED HETEROCYCLES
MX2020003993A (en) Benzimidazole derivatives and their uses.
EA200801580A1 (en) NEW PIRININOD DERIVATIVES AND METHOD FOR THEIR PRODUCTION
BR0312722A (en) Heterobicylic pyrazole derivatives as kinase inhibitors
BR0314797A (en) Pyrimidineamide derivatives and their use
ATE287267T1 (en) COMBINATION THERAPIES WITH VASCULAR DAMAGE ACTIVITY
ATE396986T1 (en) PYRIMIDYLPYRROLE DERIVATIVES THAT ACTION AS KINASE INHIBITORS
BR0313718A (en) Compound, process for the preparation thereof, pharmaceutical composition, methods for treating a human or animal subject suffering from a condition which is cox-2 mediated and for treating a human or animal subject suffering from an inflammatory disorder, and, use of a compound
NO20043792L (en) New heterocyclic compounds process for their preparation and pharmaceutical compositions containing them and their use in medicine
CO2020016480A2 (en) Topical salts of amlodipine for the treatment of anorectal diseases
NO20044498L (en) Combination therapy for the treatment of cancer
ATE413187T1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING INTERFERON TAU
SV2006002192A (en) AMIDAS OF ACID 5 AND 6-AMINOALQUIL INDOL-2-CARBOXILICO 3-SUBSTITUTES AND RELATED ANALOGS AS INHIBITORS OF CASEINA CINASA IE
BRPI0418301A (en) pharmaceutically acceptable compound or salt, method for preparing compound, pharmaceutical composition and therapeutic agent
WO2018067638A3 (en) High mobility group b1 protein inhibitors
UY26945A1 (en) PHENOXYPHENYL ALCANOSULPHONATES

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2158 DE 15/05/2012.